David M. Rodman
-
- Neuroscience of respiration and sleep 14
- Pulmonary and Respiratory Medicine top 0.5%
- Pulmonary Hypertension Research and Treatments 30
- Cystic Fibrosis Research Advances 12
- Neonatal Respiratory Health Research 11
- Physiology top 1%
- Nitric Oxide and Endothelin Effects 38
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 12
-
- Renin-Angiotensin System Studies 9
-
- Virus-based gene therapy research 6
- Co-authors
- Ivan F. McMurtryKaren A. FaganBrian FoutyRichard F. OʼBrienSteven H. AbmanJames WestRichard H. SimonBruce C. Marshall
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)Circulation (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
David M. Rodman
99 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Endocrine and Autonomic Systems 693
- Pulmonary and Respiratory Medicine 3.3k
- Physiology 2.1k
- Biochemistry 389
- Cardiology and Cardiovascular Medicine 1.2k
Countries citing papers authored by David M. Rodman
This map shows the geographic impact of David M. Rodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Rodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Rodman more than expected).
Fields of papers citing papers by David M. Rodman
This network shows the impact of papers produced by David M. Rodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Rodman. The network helps show where David M. Rodman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David M. Rodman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | Results of a phase 1b/2 trial of intravitreal (IVT) sepofarsen (QR-110) antisense oligonucleotide in Leber congenital amaurosis 10 (LCA10) due to p.Cys998X mutation in the CEP290 gene | 2020 | 3 |
| 3 | 2013 | 17 | |
| 4 | 2011 | 44 | |
| 5 | 2008 | 15 | |
| 6 | 2007 | 129 | |
| 7 | 2005 | 119 | |
| 8 | 2005 | 28 | |
| 9 | 2004 | 14 | |
| 10 | 2004 | 1 | |
| 11 | 2004 | 17 | |
| 12 | 2004 | 292 | |
| 13 | 2002 | 2 | |
| 14 | 2001 | 46 | |
| 15 | 2001 | 80 | |
| 16 | 1999 | 253 | |
| 17 | 1997 | 3 | |
| 18 | 1991 | 14 | |
| 19 | 1991 | 90 | |
| 20 | 1990 | 38 |
About David M. Rodman
David M. Rodman is a scholar working on Endocrine and Autonomic Systems, Biochemistry and Physiology, having authored 100 papers that have together received 5.6k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (38 papers), Pulmonary Hypertension Research and Treatments (30 papers), Neuroscience of respiration and sleep (14 papers), Eicosanoids and Hypertension Pharmacology (12 papers), Cystic Fibrosis Research Advances (12 papers), Neonatal Respiratory Health Research (11 papers), Renin-Angiotensin System Studies (9 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Endocrine and Autonomic Systems (693 citations), Pulmonary and Respiratory Medicine (3.3k citations) and Physiology (2.1k citations). David M. Rodman has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Ivan F. McMurtry, Karen A. Fagan, Brian Fouty, Richard F. OʼBrien, Steven H. Abman, James West, Richard H. Simon, Bruce C. Marshall, Beth Sufian and James R. Yankaskas. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.